Skip to content

Hesse and Noweda unite to defend local pharmacies against unfair competition

Local pharmacies face extinction under current laws. Can Hesse's fight for fairer fees and stricter rules save Germany's rural healthcare lifeline?

The image shows a blue background with text and a logo that reads "19 million Americans will save...
The image shows a blue background with text and a logo that reads "19 million Americans will save an estimated $400 per year on prescription drug costs".

Hesse and Noweda unite to defend local pharmacies against unfair competition

State Secretary Dr. Sonja Optendrenk from the Hessian Ministry of Health recently met with Noweda CEO Dr. Michael Kuck at the company's distribution centre. Their discussion focused on the growing challenges faced by pharmacies and pharmaceutical wholesalers in Germany. Key concerns included fair competition, economic stability, and the impact of recent legislation on local healthcare services.

Optendrenk stressed that a well-functioning healthcare system, including reliable access to medications, is essential for democracy. She highlighted the role of pharmacies as vital first points of contact, especially in rural areas, where they provide critical advice and ensure drug safety.

Kuck pointed out that pharmacies and wholesalers operate under stricter regulations than mail-order suppliers and drugstores. He argued that this unequal treatment must end to protect local healthcare and meet patient needs. Both also called for fairer economic conditions, including higher fixed fees, to help pharmacies cope with rising costs. Hesse has been vocal in opposing the 'pharmacy without a pharmacist' model and has pushed for better remuneration in the Bundesrat. The state joins other critics of the Pharmacy Supply Development Act (ApoVWG), which remains under scrutiny. A public hearing on the law is scheduled for March 4, 2026, but its current effects remain unclear.

The meeting underscored the need for stable funding and fair regulations to keep pharmacies operational. Without adequate adjustments, local healthcare access could weaken, particularly in underserved regions. The outcome of the 2026 hearing on the ApoVWG may shape future policies affecting the sector.

Read also:

Latest